sglt2 inhibitors vs glp-1 Renal outcomes of and GLP1 agonists in clinical practice Cardiovascular benefits of SGLT2 inhibitors

2023 Dec 14;389(24):2221-2232

CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells

A part of me doubted it at times, but there was an undeniable moment this past year when I put on a pair of snakeskin pants

Methods We conducted a meta-analysis of randomized controlled trials that tested GLP-1 RA treatment versus placebo in individuals with type 2 diabetes or with overweight/obesity status, with or without CKD, with kidney events reported as primary or secondary end points

Think about it like this: Your body is still processing the B12 and gearing up to function at its best